Mrs Sandra H Sawyer, LCSW | |
126 W Branch St, Suite 10, Aarroyo Grande, CA 93420 | |
(805) 474-0105 | |
(805) 489-3434 |
Full Name | Mrs Sandra H Sawyer |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 126 W Branch St, Aarroyo Grande, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740408434 | NPI | - | NPPES |
11332348 | Other | CAQH UNIVERSAL CREDENTIAL | |
12477 | Other | CA | LCSW |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | LCS12477 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Sandra H Sawyer, LCSW 228 Ruth Ann Way, Arroyo Grande, CA 93420 Ph: (805) 474-0105 | Mrs Sandra H Sawyer, LCSW 126 W Branch St, Suite 10, Aarroyo Grande, CA 93420 Ph: (805) 474-0105 |
News Archive
A deep-learning computer network developed through research led by Case Western Reserve University was 100 percent accurate in determining whether invasive forms of breast cancer were present in whole biopsy slides.
In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.
The Critical Path Institute and H. Lundbeck A/S are proud to announce that they will work together to significantly improve the scientific community's insight in Alzheimer's disease through Lundbeck's contribution of a unique set of clinical trial data from more than 2,500 AD patients to the Critical Path for Alzheimer's Disease consortium's integrated database for qualified researchers across the globe to access.
Since many hospitals now work to help keep costs down by watching what drugs are used, pharmaceutical representatives must include administrators in their sales pitches. Also in the news, new concerns about the government's plan to open a database next week on drug makers' payments to doctors.
Today, the U.S. Food and Drug Administration is warning the public not to use medical devices marketed to consumers that claim to help assess, diagnose or manage head injury, including concussion, traumatic brain injury (TBI) or mild TBI.
› Verified 4 days ago